Effectiveness of the Bedaquiline, Pretomanid, and Linezolid Regimen, With or Without Moxifloxacin, for Drug-Resistant Tuberculosis in Ukraine Under Programmatic Conditions
Clinical Infectious Diseases · 2025
DOI: 10.1093/cid/ciaf214 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Infectious Diseases, 2025. Verfasst von Victor Naestholt Dahl und 24 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark. Hauptthemen laut MEDLINE: Linezolid, Moxifloxacin, Diarylquinolines, Tuberculosis, Multidrug-Resistant. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Institute of Allergy and Infectious Diseases, US Civilian Research & Development Foundation, CRDF Global.
Abstract (Originalsprache)
Bedaquiline, pretomanid, and linezolid, with or without moxifloxacin, have revolutionized treatment for drug-resistant tuberculosis. In Ukraine, we observed an 86% success rate (394 of 460) under programmatic conditions when drugs were accessible, exceeding prior estimates (58%) and aligning with trial findings (80%–90%). However, access and implementation remain a concern in conflict-affected settings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark.
- Department of Respiratory Diseases and Allergy, Aarhus University Hospital, Aarhus, Denmark.
- Outpatient Department, Merefa Central District Hospital, Merefa, Ukraine.
- Department of Chemoresistant Tuberculosis, National Institute of Phthisiology and Pulmonology Named After F. G. Yanovskyi NAMS of Ukraine, Kyiv, Ukraine.
- Department of Phthisiology and Pulmonology, Zaporizhzhia State Medical and Pharmaceutical University, Zaporizhzhia, Ukraine.
- The Pulmonary Tuberculosis Department No. 2, Zaporizhzhia Regional Phthisiology and Pulmonology Clinical Treatment and Diagnostic Center, Zaporizhzhia, Ukraine.
ORCID-Profile: Victor Naestholt Dahl, Ole Skouvig Pedersen, Tetiana Butova, Olena Raznatovska, Vitalii Vekshyn, Leonid Hryshchuk, Artemii Bogomolov, Daria Yankovska, Mykola Ostrovskyy, Iryna Makoida, Dmytro Butov
Förderung
- National Institute of Allergy and Infectious Diseases
- US Civilian Research & Development Foundation
- CRDF Global
- Ministry of Health of Ukraine
Zitieren
APA
Dahl, V. N., Skouvig Pedersen, O., Butova, T., Kuzhko, M., Raznatovska, O., Fedorec, A., Vekshyn, V., Hlynenko, V., Yevsiukova, N., Hryshchuk, L., Kornaha, S., Chursina, N., Kondratyuk, N., Markovtsiy, L., Skryp, V., Bogomolov, A., Klymenko, T., Yankovska, D., Ostrovskyy, M., …, & Butov, D. (2025). Effectiveness of the Bedaquiline, Pretomanid, and Linezolid Regimen, With or Without Moxifloxacin, for Drug-Resistant Tuberculosis in Ukraine Under Programmatic Conditions. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciaf214
Vancouver
Dahl VN, Skouvig Pedersen O, Butova T, Kuzhko M, Raznatovska O, Fedorec A, et al. Effectiveness of the Bedaquiline, Pretomanid, and Linezolid Regimen, With or Without Moxifloxacin, for Drug-Resistant Tuberculosis in Ukraine Under Programmatic Conditions. Clinical Infectious Diseases. 2025. doi:10.1093/cid/ciaf214
BibTeX
@article{Dahl2025,
author = {Dahl, Victor Naestholt and Skouvig Pedersen, Ole and Butova, Tetiana and Kuzhko, Mykhailo and Raznatovska, Olena and Fedorec, Andrii and Vekshyn, Vitalii and Hlynenko, Valentyna and Yevsiukova, Nataliia and Hryshchuk, Leonid and Kornaha, Svitlana and Chursina, Nataliia and Kondratyuk, Natalia and Markovtsiy, Lyubov and Skryp, Vasyl and Bogomolov, Artemii and Klymenko, Tetiana and Yankovska, Daria and Ostrovskyy, Mykola and Makoida, Iryna and Levandovska, Daria and Shpak, Yuulia and Didyk, Vitalii and Siomak, Olha and Butov, Dmytro},
title = {Effectiveness of the Bedaquiline, Pretomanid, and Linezolid Regimen, With or Without Moxifloxacin, for Drug-Resistant Tuberculosis in Ukraine Under Programmatic Conditions},
journal = {Clinical Infectious Diseases},
year = {2025},
doi = {10.1093/cid/ciaf214}
}
EUVIMED